GO:0090036 regulation of protein kinase C signaling: Signaling Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0090036 describes any process that modulates the frequency, rate, or extent of signaling mediated by protein kinase C (PKC), a family of intracellular serine/threonine kinases.
PKC signaling is triggered by second messengers such as diacylglycerol (DAG) and calcium, which recruit PKC to membranes and relieve autoinhibition.
Regulation occurs at multiple levels: phosphorylation, lipid binding, subcellular localization, and isoform-specific crosstalk.
PKC signaling controls diverse outputs including apoptosis, inflammation, receptor modulation, and transcriptional programs.
Dysregulated PKC signaling is implicated in cancer, inflammatory diseases, and neurological disorders.
CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of PKC regulatory nodes.

Description

Protein kinase C (PKC) is a family of intracellular serine/threonine kinases that transduce signals from membrane receptors to diverse cellular responses. The Gene Ontology term GO:0090036, regulation of protein kinase C signaling, captures any process that modulates the frequency, rate, or extent of the signaling cascade mediated by PKC. This term is essential for annotating how cells fine-tune PKC activity in space and time, because PKC signaling is not a simple on/off switch but a highly regulated network. Understanding GO:0090036 is critical for researchers studying signal transduction, because perturbations in PKC regulation underlie numerous pathologies, including cancer, inflammation, and neurodegeneration. Moreover, PKC isoforms exhibit distinct regulatory mechanisms and crosstalk, making the term a hub for systems-level analysis. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0090036, its mechanisms, key genes, disease relevance, and experimental approaches.

regulation of protein kinase C signaling At A Glance

GO ID GO:0090036
GO term regulation of protein kinase C signaling
Ontology biological_process
Synonym regulation of protein kinase C signaling cascade; regulation of protein kinase C signalling cascade
Major function Modulates the frequency, rate, or extent of signaling mediated by protein kinase C (PKC)
Trigger Second messengers such as diacylglycerol (DAG) and calcium, or receptor-mediated activation
Key kinase family Protein kinase C (PKC) isoforms (e.g., PKCα, PKCβ, PKCδ, PKCε)
Subcellular context Cytoplasm, plasma membrane, nucleus, and other organelles
Disease relevance Cancer, inflammation, neurological disorders

What Is GO:0090036?

GO:0090036 is defined as any process that modulates the frequency, rate, or extent of a series of reactions mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound. In simpler terms, it encompasses all regulatory inputs that control PKC signaling, including changes in PKC abundance, activity, localization, or interactions with other proteins.

Why Is regulation of protein kinase C signaling Important in Cell Biology?

GO:0090036 is important because PKC signaling is a central node in cellular signal transduction, and its dysregulation contributes to major human diseases. The term enables precise annotation of regulatory mechanisms that control PKC activity, which is essential for understanding how cells respond to external stimuli and how therapeutic interventions can be designed.
PKC signaling regulates cell proliferation, differentiation, and survival, making its modulation critical in cancer.
PKC is involved in inflammatory responses, including regulation of inducible nitric oxide synthase.
PKC modulates ion channels and neurotransmitter receptors, impacting neuronal excitability.
PKC signaling influences apoptosis, with roles in radiation-induced cell death.
Isoform-specific regulation of PKC determines differential cellular responsiveness.
PKC translocates to the nucleus and regulates transcription, linking signaling to gene expression.
Dysregulated PKC signaling is implicated in skin diseases and tumor epithelium.
Understanding PKC regulation aids in drug development targeting PKC pathways.
PKC crosstalk with other signaling cascades (e.g., metabotropic glutamate receptors) fine-tunes synaptic function.
GO:0090036 provides a framework for annotating high-throughput data on PKC regulatory networks.

What Happens During regulation of protein kinase C signaling?

Trigger and membrane recruitment
In simple terms: PKC is activated when signals bring it to the cell membrane.
PKC signaling is initiated by triggers such as diacylglycerol (DAG) and calcium, which recruit PKC to the plasma membrane. This recruitment is mediated by lipid-binding domains and relieves autoinhibition, allowing PKC to phosphorylate substrates. Regulation of this step includes modulation of second-messenger production and membrane lipid composition.
Phosphorylation and maturation
In simple terms: PKC must be phosphorylated to become fully active.
PKC undergoes phosphorylation at specific sites, which stabilizes the kinase and primes it for activation. This maturation process is tightly regulated and influences PKC stability and subcellular localization. Isoform-specific phosphorylation patterns contribute to differential signaling outcomes.
Subcellular localization and scaffolding
In simple terms: Where PKC goes in the cell determines what it does.
PKC interacts with scaffolding proteins that target it to specific compartments, including the nucleus, mitochondria, and cytoskeleton. This spatial regulation ensures substrate specificity and is a key aspect of GO:0090036. Nuclear PKC can regulate transcription, linking signaling to gene expression.
Isoform-specific crosstalk and feedback
In simple terms: Different PKC isoforms can influence each other.
PKC isoforms exhibit reciprocal regulation, where activation of one isoform can modulate the activity of another, leading to differential cellular responsiveness. This crosstalk is part of the regulatory network captured by GO:0090036. Feedback loops involving phosphatases and other kinases also terminate or sustain PKC signaling.
Downstream effector modulation
In simple terms: PKC changes the behavior of other proteins.
Activated PKC phosphorylates diverse substrates, including receptors, ion channels, and transcription factors, thereby altering cellular responses such as apoptosis, inflammation, and synaptic plasticity. Regulation of these downstream events is integral to the term.

Key Genes Involved in GO:0090036 regulation of protein kinase C signaling

The following genes and proteins are central to the regulation of protein kinase C signaling (GO:0090036), based on verified literature.
GeneMajor RoleResearch Relevance
PRKCAPKCα isoform; mediates DAG/calcium-dependent signalingImplicated in cancer and cardiac disease
PRKCBPKCβ isoform; involved in immune and neuronal signalingTarget for inflammatory and neurological studies
PRKCDPKCδ isoform; regulates apoptosis and inflammationKey player in radiation-induced apoptosis
PRKCEPKCε isoform; promotes cell survival and tumorigenesisStudied in cancer and pain
PRKCZPKCζ isoform; atypical PKC involved in polarity and NF-κBLinked to inflammation and cancer
DGKDiacylglycerol kinase; terminates DAG signalingRegulates PKC activation
PLCBPhospholipase C beta; produces DAG and IP3Upstream regulator of PKC
GNAQG protein subunit; activates PLCBMutated in uveal melanoma, affecting PKC
RACK1Scaffold protein for PKCModulates PKC localization and substrate specificity
PDPK1Phosphoinositide-dependent kinase 1; phosphorylates PKCRequired for PKC maturation
CASP3Caspase-3; cleaves PKCδ during apoptosisLinks PKC to apoptotic pathways
NOS2Inducible nitric oxide synthase; regulated by PKCInflammation model
GRM1Metabotropic glutamate receptor 1; modulates PKCNeuronal signaling
GRIK1Kainate receptor subunit; regulated by PKCSynaptic plasticity
TNFTumor necrosis factor; activates PKC via receptorsInflammation and cancer
EGFREpidermal growth factor receptor; crosstalk with PKCCancer signaling
SRCSrc kinase; interacts with PKCCancer and adhesion

How Is regulation of protein kinase C signaling Regulated?

Regulation of PKC signaling (GO:0090036) is itself controlled by multiple mechanisms. Upstream, G-protein-coupled receptors and receptor tyrosine kinases activate phospholipase C to generate DAG and calcium, which recruit PKC to membranes. Phosphorylation by PDPK1 and other kinases is required for PKC maturation. Scaffolding proteins such as RACK1 target PKC to specific substrates. Feedback loops involving diacylglycerol kinases and phosphatases terminate signaling. Isoform-specific crosstalk further fine-tunes responses. In the nucleus, PKC regulates transcription factors, adding another layer of control.

regulation of protein kinase C signaling and Human Disease

GeneDisease / BiologyPotential Experimental Model
PRKCACancer, cardiac hypertrophyKnockout mice, point-mutation knock-in
PRKCDApoptosis, autoimmune diseaseConditional knockout, overexpression
PRKCECancer, painTransgenic overexpression, knockout
NOS2InflammationReporter knock-in, knockout
GRIK1Epilepsy, synaptic plasticityPoint-mutation knock-in
Cancer
PKC signaling is frequently dysregulated in cancer. PKC isoforms can act as tumor promoters or suppressors depending on context. For example, PKCε promotes survival and is overexpressed in several cancers, while PKCδ can induce apoptosis. Mutations in upstream regulators like GNAQ alter PKC activity in uveal melanoma. Targeting PKC regulatory nodes is a therapeutic strategy.
Inflammatory diseases
PKC signaling regulates inflammatory mediators, including inducible nitric oxide synthase (NOS2). PKC inhibitors reduce inflammation in models of sepsis and arthritis. Isoform-specific regulation of PKC affects immune cell responsiveness.
Neurological disorders
PKC modulates ion channels and neurotransmitter receptors, influencing synaptic plasticity and neuronal survival. Dysregulation of PKC signaling is implicated in epilepsy, Alzheimer's disease, and pain. Kainate receptor regulation by PKC is a key mechanism in excitotoxicity.
Skin diseases
PKC isoforms are critical for skin homeostasis and tumorigenesis. Altered PKC signaling contributes to psoriasis and squamous cell carcinoma.

From regulation of protein kinase C signaling-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of PKCα affect tumor growth?PRKCA knockout cell lines and mouse models
How does PKCδ phosphorylation regulate apoptosis?Point-mutation knock-in of phospho-deficient PKCδ
What is the role of PKCε in pain signaling?PRKCE knockout mice
How does PKC regulate NOS2 expression?NOS2 promoter reporter knock-in
Does PKC-mediated phosphorylation of kainate receptors alter excitability?GRIK1 point-mutation knock-in
Can PKC isoform crosstalk be dissected?Double knockout or overexpression models

How to Study the regulation of protein kinase C signaling Process

MethodWhat It MeasuresTypical Application
PhosphoproteomicsGlobal phosphorylation changesIdentify PKC substrates
Live-cell imagingPKC localization and activityStudy spatiotemporal dynamics
CRISPR knockout screenGenes affecting PKC signalingDiscover regulators
RNA-seqTranscriptional changesNuclear PKC function
Western blotPKC phosphorylation statusValidate activation
Kinase activity assayPKC enzymatic activityMeasure regulation
FRET biosensorsPKC activity in real timeLive-cell signaling
Co-immunoprecipitationPKC-protein interactionsIdentify scaffolds
Phosphoproteomics
Mass spectrometry-based phosphoproteomics identifies PKC substrates and phosphorylation sites, revealing regulatory networks. This method quantifies changes in phosphorylation upon PKC activation or inhibition.
Live-cell imaging
Fluorescently tagged PKC isoforms and biosensors enable real-time monitoring of PKC translocation and activity in living cells. This reveals spatiotemporal regulation.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes that regulate PKC signaling, such as phosphatases or scaffolds. These screens link genotype to PKC activity.
Transcriptomics
RNA-seq after PKC modulation reveals downstream transcriptional programs, especially nuclear PKC functions. This connects signaling to gene expression.

How CRISPR Can Be Used to Study GO:0090036 regulation of protein kinase C signaling

Knockout

CRISPR knockout of PKC isoforms or regulators (e.g., PRKCA, PRKCD) ablates protein function, enabling loss-of-function studies. This is used to determine necessity in signaling pathways.

Point Mutation

Point mutations can be introduced to mimic or prevent phosphorylation (e.g., phospho-deficient PKC mutants), dissecting specific regulatory sites.

Knock-in

Knock-in of tagged PKC (e.g., GFP-PKC) allows visualization and pull-down of endogenous protein, revealing localization and interactions.

Overexpression

Overexpression of wild-type or mutant PKC isoforms via CRISPR activation or lentiviral delivery tests gain-of-function effects, such as oncogenic potential.

How EDITGENE Supports regulation of protein kinase C signaling Research

Researchers studying regulation of protein kinase C signaling-related genes often need to determine whether a candidate gene is causally involved in modulating PKC activity, localization, or downstream outputs. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of protein kinase C signaling research.

Frequently Asked Questions About regulation of protein kinase C signaling

GO:0090036 is the Gene Ontology term for regulation of protein kinase C signaling, describing any process that modulates the frequency, rate, or extent of PKC-mediated signaling.
Key genes include PRKCA, PRKCB, PRKCD, PRKCE, PRKCZ, DGK, PLCB, and RACK1, among others.
PKC signaling is regulated by second messengers (DAG, calcium), phosphorylation, subcellular localization, scaffolding proteins, and isoform-specific crosstalk.
Dysregulated PKC signaling is linked to cancer, inflammatory diseases, neurological disorders, and skin diseases.
The main isoforms include PKCα, PKCβ, PKCγ, PKCδ, PKCε, PKCη, PKCθ, and PKCζ, each with distinct regulatory properties.
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of PKC regulatory mechanisms.
Common methods include phosphoproteomics, live-cell imaging, CRISPR screens, RNA-seq, and kinase activity assays.
PKC isoforms can promote or suppress tumors, and their regulation affects proliferation, survival, and metastasis.
PKC regulates inflammatory mediators such as inducible nitric oxide synthase, and PKC inhibitors reduce inflammation.
PKC modulates ion channels and neurotransmitter receptors, influencing synaptic plasticity and excitability.

Conclusion

GO:0090036, regulation of protein kinase C signaling, is a critical biological process that governs how cells interpret and respond to diverse stimuli. Its complexity arises from multiple layers of regulation, including second messengers, phosphorylation, localization, and isoform crosstalk. Dysregulation of this process contributes to cancer, inflammation, and neurological disorders, making it a prime target for therapeutic intervention. CRISPR-based models and advanced omics technologies continue to unravel the intricate regulatory networks, offering new opportunities for drug discovery and precision medicine.

References

  1. 1. Kazanietz MG et al.. 2024. Protein kinase C signaling "in" and "to" the nucleus: Master kinases in transcriptional regulation.. J Biol Chem 300(3):105692 PMID: 38301892
  2. 2. Nakajima T. 2006. Signaling cascades in radiation-induced apoptosis: roles of protein kinase C in the apoptosis regulation.. Med Sci Monit 12(10):RA220-4 PMID: 17006414
  3. 3. Toker A. 1998. Signaling through protein kinase C.. Front Biosci 3:D1134-47 PMID: 9792904
  4. 4. Breitkreutz D et al.. 2007. Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium.. J Cancer Res Clin Oncol 133(11):793-808 PMID: 17661083
  5. 5. Spitaler M et al.. 2004. Protein kinase C and beyond.. Nat Immunol 5(8):785-90 PMID: 15282562
  6. 6. Sudan R et al.. 2012. Reciprocal regulation of protein kinase C isoforms results in differential cellular responsiveness.. J Immunol 188(5):2328-37 PMID: 22271653
  7. 7. Leppänen T et al.. 2014. Protein kinase C and its inhibitors in the regulation of inflammation: inducible nitric oxide synthase as an example.. Basic Clin Pharmacol Toxicol 114(1):37-43 PMID: 24107256
  8. 8. Cho K et al.. 2003. Regulation of kainate receptors by protein kinase C and metabotropic glutamate receptors.. J Physiol 548(Pt 3):723-30 PMID: 12640005
Contact Us
*
*
*
*
How did you hear about us: